logo

For the Inventor, By the Inventor

Jeffersonville, PA, United States of America

Nicholas J Sisti

This inventor holds 14 USPTO granted patents. Top assignees: Napro Biotherapeutics, Inc., Bryn Mawr College, Anadys Pharmaceuticals, Inc.. Active years: 1997-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicholas J Sisti. Retrieved from https://idiyas.com/inventor/nicholas-j-sisti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14

% Patents Active = 92.9

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 85(Granted Patents)


Location History:

  • Jeffersonville, PA (US) (1997 - 1999)
  • Boulder, CO (US) (1999 - 2000)
  • Pepperrell, MA (US) (2000)
  • Mineola, NY (US) (2000)
  • Pepperell, MA (US) (1999 - 2002)

Company Filing History:

goldMedal12 out of 33 
 
Napro Biotherapeutics, Inc.
 patents
silverMedal6 out of 13 
 
Bryn Mawr College
 patents
bronzeMedal1 out of 51 
 
Anadys Pharmaceuticals, Inc.
 patents
4. 1 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1997-2002

Loading Chart...
14 patents (USPTO):Explore Patents
1. 6448417 - Methods and useful intermediates for paclitaxel synthesis from C-7, C-10 di-cbz 10-deacetylbaccatin III (2002-09-10),
2. 6329378 - Hydrazone, hydrazine and thiosemicarbazone derivatives as antifungal agents (2001-12-11),
3. 6133462 - C-7 CBZ baccatin III and production method therefor (2000-10-17),
4. 6107497 - Intermediate for use in docetaxel synthesis and production method (2000-08-22),
5. 6066749 - Method for conversion of C-2'-O-protected-10-hydroxy taxol to (2000-05-23),
6. 6048990 - Method for selective acylation of C-2'-O-protected-10-hydroxy-taxol at (2000-04-11),
7. 5973170 - C-7 metal alkoxides of baccatin III (1999-10-26),
8. 5948919 - Paclitaxel synthesis from precursor compounds and methods of producing (1999-09-07),
9. 5914411 - Alternate method for acylating 10-deacetylbaccatin III selectively at (1999-06-22),
10. 5750737 - Method for paclitaxel synthesis (1998-05-12),
11. 5750736 - Method for acylating 10-deacetylbaccatin III selectively at the c-10 (1998-05-12),
12. 5688977 - Method for docetaxel synthesis (1997-11-18),
13. 5684175 - C-2' hydroxyl-benzyl protected, N-carbamate protected (2R, 3S)- (1997-11-04),
14. 5675025 - Paclitaxel synthesis from precursor compounds and methods of producing (1997-10-07),

Title: The Innovative Journey of Nicholas J Sisti: Pioneering Patents and Collaborations

Introduction:

Nicholas J Sisti, a remarkable inventor hailing from Jeffersonville, PA, has left an indelible mark in the realm of pharmaceutical innovations. With an impressive portfolio of 14 patents, his groundbreaking work in synthesizing paclitaxel and developing antifungal agents has propelled the field of medicinal chemistry forward.

Latest Patents:

Sisti's latest patents revolve around novel methods for paclitaxel synthesis, showcasing his expertise in chemical processes. The inventions not only streamline the production of paclitaxel and its analogs but also pave the way for enhanced drug development in the fight against cancer. Additionally, his contributions to antifungal agents highlight his versatility in addressing diverse medical challenges.

Career Highlights:

Having worked at esteemed institutions such as Napro Biotherapeutics, Inc. and Bryn Mawr College, Sisti has honed his skills in the pharmaceutical industry. His dedication to advancing drug discovery and development has earned him recognition as a pioneer in the field of medicinal chemistry. Sisti's relentless pursuit of innovation is evident in each of his patents, reflecting his passion for scientific excellence.

Collaborations:

Throughout his career, Sisti has collaborated with esteemed professionals such as Charles S Swindell and Madhavi C Chander. These partnerships have not only enriched his research endeavors but have also fostered a culture of collaboration and knowledge sharing within the scientific community. By working alongside talented individuals, Sisti has been able to push the boundaries of innovation and achieve remarkable breakthroughs in pharmaceutical research.

Conclusion:

In conclusion, Nicholas J Sisti stands as a beacon of innovation in the field of medicinal chemistry. His exceptional contributions to paclitaxel synthesis and antifungal agent development underscore his profound impact on the healthcare industry. As a visionary inventor, Sisti continues to inspire future generations of scientists to push the boundaries of knowledge and drive meaningful change through their inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…